From iGEMers! LabGenius Raises $10M To Apply AI For Protein Drug Discovery
James Field recently announced via TechCrunch that LabGenius raised $10M in SeriesA Funding.
LabGenius was conceived during his PhD studies at Imperial College London, where his research was focused on re-engineering protein nanocages for biotechnological applications. James formally founded LabGenius back in 2012 with the goal to use machine learning-driven evolution engine (EVA™️) to develop next generation of protein therapeutics.
“LabGenius is a full-stack protein engineering company: we combine artificial intelligence (AI), robotic automation and synthetic biology to evolve next-generation protein therapeutics,” founder and CEO Dr. James Field told TechCrunch
You can read more about the story at this link